Human cytochromes P450 expressed in Escherichia coli: Production of specific antibodies

Toxicology

Volumn 106, Issue 1-3, 1996, Pages 207-219

  Belloc, Claire ^a   Baird, Susan ^a   Cosme, José ^a   Lecoeur, Sylvaine ^a   Gautier, Jean Charles ^a   Challine, Dominique ^a   De Waziers, Isabelle ^a   Flinois, Jean Pierre ^a   Beaune, Philippe H ^a  

^a INSERM   (France)

Author keywords

Antibody; E. Coli; Heterologous expression; Human CYP; Metabolism; Xenobiotic

Indexed keywords

CYTOCHROME P450 ISOENZYME; ENZYME ANTIBODY; HEME;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; ESCHERICHIA COLI; FEMALE; HUMAN; HUMAN TISSUE; LIVER MICROSOME; NONHUMAN; PRIORITY JOURNAL; XENOBIOTIC METABOLISM; YEAST;

ANTIBODIES; ANTIBODY FORMATION; ANTIBODY SPECIFICITY; ARYL HYDROCARBON HYDROXYLASES; BLOTTING, WESTERN; CLONING, MOLECULAR; CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 CYP3A; CYTOCHROME P-450 ENZYME SYSTEM; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ESCHERICHIA COLI; GENE EXPRESSION; HEME; HUMANS; MICROSOMES, LIVER; OXIDOREDUCTASES; OXIDOREDUCTASES, N-DEMETHYLATING; RECOMBINANT PROTEINS;

ANIMALIA; ESCHERICHIA COLI;

EID: 0029671175     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0300-483X(95)03178-I     Document Type: Article

References (46)

1. Beaune, P., Kremers, P., Letawe-Goujon, F. and Gielen, J.E. (1985) Monoclonal antibodies against human liver cytochrome P-450;. Biochem. Pharmacol. 34, 3547-3552.
2. Berthou, F., Dreano, Y., Belloc, C., Kangas, L., Gautier, J.-C. and Beaune, P. (1994) Involvement of cytochrome P450 3A enzyme family in the major metabolic pathways of toremifene in human liver microsomes. Biochem. Pharmacol. 47, 1883-1895.
3. Bourdi, M., Gautier, J.-C., Mircheva, J., Larrey, D., Guillouzo, A., André, C., Belloc, C. and Beaune, P.H. (1992) Anti-liver microsomes autoantibodies and dihydralazine-induced hepatitis: specificity of autoantibodies and inductive capacity of the drug. Mol. Pharmacol. 42, 280-285.
4. PA (P-450 1A2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc. Natl. Acad. Sci. USA 86, 7696-7700.
5. Cateau, A., Douriez, E., Beaune, P., Poisson, N., Bonaiti-Pellié, C. and Laurent, P. (1995) Genetic polymorphism of induction of CYP1A1 (EROD) activity. Pharmacogenetics 5, 110-119.
6. Crespi, C.L., Langenbach, R. and Penman, B.W. (1993) Human cell lines, derived from AHH-1 TK+/-human lymphoblasts, genetically engineered for expression of cytochromes-P450. Toxicology 82, 89-104.
7. Cullin, C. and Pompon, D. (1988) Synthesis of functional mouse cytochromes P-450 P1 and chimeric P-450P3-1 in the yeast Saccharomyces cerevisiae. Gene 65, 203-217.
8. De Waziers, I., Cugnenc, P.H., Yang, C.S., Leroux, J.-P. and Beaune, P.H. (1990) Cytochrome P450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues. J. Pharmacol. Exp. Ther. 253, 387-394.
9. Dubendorf, J.W. and Studier, F.W. (1991) Controlling basal expression in an inducible T7 expression system by blocking the target T7 promoter with lac repressor. J. Mol. Biol. 219, 45-59.
10. Eugster, H.-P., Sengstag, C., Meyer, U.A., Hinnen, A. and Würgler, F. E. (1990) Constitutive and inducible expression of human cytochrome P-450 1A1 in yeast Saccharomyces cerevisiae : an alternative enzyme source for in vitro studies. Biochem. Biophys. Res. Commun. 172, 737-744.
11. Fisher, C.W., Caudle, D.L., Martin-Wixtrom, C., Quattrochi, L.C., Tukey, R.H., Waterman, M.R. and Estabrook, R.W. (1992) High-level expression of functional human cytochrome P450 1A2 in Escherichia coli. FASEB J. 6, 759-764.
12. Gautier, J.C., Urban, P., Beaune, P. and Pompon, D. (1993) Engineered yeast cells as model to study coupling between human xenobiotic metabolizing enzymes - Simulation of the 21st steps of Benzo[a]pyrene activation. Eur. J. Biochem. 211, 63-72.
13. Guan, K. and Dixon, J.E. (1991) Eukaryotic proteins expressed in Escherichia coli: an improved thrombin cleavage procedure of fusion protein with glutathion S-transferase. Anal. Biochem. 192, 262-267.
14. Guengerich, F.P. (1993) Cytochrome-P450 Enzymes. American Scientist 81, 440-447.
15. Guengerich, F.P. and Turvy, C.G. (1990) Comparison of levels of several human microsomal cytochrome P-450 enzymes and epoxide hydrolase in normal and disease states using immunochemical analysis of surgical liver samples. J. Pharmacol. Exp. Ther. 256, 1189-1194.
16. Guengerich, F.P., Dannan, G.A., Wright, S.T., Martin, M.V. and Kaminsky, L.S. (1982) Purification and characterization of liver microsomal cytochromes P-450: electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or β-naphtoflavone. Biochemistry 21, 6019-6031.
17. Kalow, M.W. (1991) Caffeine as a metabolic probe: Exploration of the enzyme-inducing effect of cigarette smoking. Clin. Pharmacol. Ther. 49, 44-48.
18. Kouri, R.E., McKinney, C.E., Slomiani, D.J., Snodgrass, D.R., Wray, N.P. and McLemore, T.L. (1982) Positive correlation between high aryl hydrocarbon hydroxylase activity and primary lung cancer as analyzed in cryoconserved lymphocytes. Cancer Res. 42, 5030-5037.
19. Kremers, P., Beaune, P., Cresteil, T., De Graeve, J., Columelli, S., Leroux, J.-P. and Gielen, J.E. (1981) Cytochrome P-450 monooxygenase activity in human and rat liver microsomes. Eur. J. Biochem. 118, 599-605.
20. Krishna, D.R. and Klotz, U. (1994) Extrahepatic metabolism of drugs in humans. Clin. Pharmacokin. 26, 144-160.
21. Laemmli, U.K. (1970) Cleavage of structural properties during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
22. Larson, J.R., Coon, M.J. and Porter, T.D. (1991) Alcohol-inducible cytochrome P450 2E1 lacking the hydrophobic NH2-terminal retains catalytic activity and is membrane-bound when expressed in Escherichia coli. J. Biol. Chem. 266, 7321-7324.
23. Lecoeur, S., Bonierbale, E., Challine, D., Gautier, J.C., Valadon, P., Dansette, P.M., Catinot, R., Ballet, F., Mansuy, D. and Beaune, P.H. (1994) Specificity of in vitro covalent binding of tienilic acid metabolites to human liver microsomes in relationship to the type of hepatotoxicity: Comparison with two directly hepatotoxic drugs. Chem. Res. Toxicol. 7, 434-442.
24. Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J. (1951) Protein measurement with the Folin reagent. J. Biol. Chem. 193, 265-275.
25. Lubet, R.A., Mayer, R.T., Cameron, J.W., Nims, R.W., Burke, M.B., Wolff, T. and Guengerich, F.P. (1985) Dealkylation of pentoxyresorufin: a rapid and sensitive assay for measuring induction of cytochrome(s) P-450 by phenobarbital and other xenobiotics in the rat. Arch. Biochem. Biophys. 238, 43-48.
26. Manns, M., Johnson, E.F., Griffin, K.J., Tan, E.M. and Sullivan, K.F. (1989) The major target antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450 dbl. J. Clin. Invest. 83, 1066-1072.
27. Murray, B.P., Edwards, R.J., Murray, S., Singleton, A.M., Davies, D.S. and Boobis, A.R. (1993) Human hepatic CYP1A1 and CYP1A2 content, determined with specific anti-peptide antibodies, correlates with the mutagenic activation of PhIP. Carcinogenesis 14, 585-592.
28. Namkung, M.J., Yang, H.L. and Juchau, M.R. (1989) On the substrate specificity of cytochrome P450 3A1. Mol. Pharmacol. 34, 628-637.
29. Nelson, D.R., Kamataki, T., Waxman, D.J., Guengerich, F.P., Estabrook, R.W., Feyereisen, R., Gonzalez, F.J., Coon, M.J., Gunsalus, I.C., Gotoh, O., Okuda, K. and Nebert, D.W. (1993) The P450 superfamily - Update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA Cell Biol. 12, 1-51.
30. Omura, T. and Sato, R. (1964) The carbon monoxide-binding pigment of liver microsomes. J. Biol. Chem. 239, 2379-2385.
31. Pompon, D. (1988) cDNA and functional expression in yeast Saccharomyces cerevisiae of β-naphtoflavone-induced rabbit liver P-450 LM4 and LM6. Eur. J. Biochem. 177, 285-293.
32. Renaud, J.-P., Cullin, C., Pompon, D., Beaune, P. and Mansuy, D. (1990) Expression of human liver cytochrome P450 3A4 in yeast. A functional model for the hepatic enzyme. FEBS Lett. 194, 889-896.
33. Renaud, J.P., Peyronneau, M.A., Urban, P., Truan, G., Cullin, C., Pompon, D., Beaune, P. and Mansuy, D. (1993) Recombinant yeast in drug metabolism. Toxicology 82, 39-52.
34. Ryan, D.E. and Levin, W. (1992) Purification and characterization of hepatic microsomal cytochrome P-450. In: W. Kalow (Eds), Pharmacogenetics of Drug Metabolism, Pergamon Press, pp. 453-547.
35. Sesardic, D., Boobis, A.R., Edwards, R.J. and Davies, D.S. (1988) A form of cytochrome P450 in man, orthologous to form d in the rat, catalyses the O-deethylation of phenacetin and is inducible by cigarette smoking. Br. J. Clin. Pharmacol. 26, 363-372.
36. Shimada, T., Yamazaki, H., Mimura, M., Inui, Y. and Guengerich, F.P. (1994) Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Ther. 270, 414-423.
37. Smith, D.B. and Johnson, K.S. (1988) Single-step purification of polypeptides expressed in Eschericia coli as fusions with glutathione S-transferase. Gene 67, 31-40.
38. Srivastava, P.K., Yun, C.-H., Beaune, P.H., Ged, C. and Guengerich, F.P. (1991) Separation of human liver microsomal tolbutamide hydroxylase and (S)-mephenytoin 4′-hydroxylase cytochrome P-450 enzymes. Mol. Pharmacol. 40, 69-79.
39. Studier, W.F., Rosenberg, A.H., Dunn, J.J. and Dubendorf, J.W. (1990) Use of T7 RNA polymerase to direct expression of cloned genes. In: D.V. Goedel (Eds), Methods in Enzymology, Vol. 185, Academic Press, NY, pp. 60-89.
40. Studier, F.W. (1991) Use of bacteriophage T7 lysozyme to improve an inducible T7 expression system. J. Mol. Biol. 219, 37-44.
41. Truan, G., Cullin, C., Reisdorf, P., Urban, P. and Pompon, D. (1993) Enhanced in vivo monooxygenase activities of mammalian P450s in engineered yeast cells producing high levels of NADPH-P450 reductase and human cytochrome b5. Gene 125, 49-55.
42. Walker, D., Flinois, J.-P., Monkman, S.C., Belloc, C., Boddy, A.V., Cholerton, S., Daly, A.K., Lind, M.J., Pearson, A.D.J., Beaune, P. H. and Idle, J.R. (1994) Identification of the major human hepatic cytochrome P450 involved in activation and N-dechloroethylation of ifosfamide. Biochem. Pharmacol. 47, 1157-1163.
43. Waterman, M.R. (1993) Heterologous expression of cytochrome-P-450 in Escherichia coli. Biochem. Soc Trans. 21, 1081-1085.
44. Watkins, P.B., Wrighton, S.A., Schuetz, E.G., Molowa, D.T. and Guzelian, P.S. (1987) Identification of glucocorticoid cytochrome P-450 in the intestinal mucosa of rats and human. J. Clin. Invest. 80, 1029-1036.
45. Wölfel, C., Heinrisch-Hirsch, B., Schulz-Schalge, T., Seidel, A., Frank, H., Ramp, U., Wächter, F., Wiebel, F.J., Gonzalez, F., Greim, H. and Doehmer, J. (1992) Genetically engineered V79 Chinese hamster cells for stable expression of human cytochrome P4501A2. Eur. J. Pharmacol. Env. Tox. Pharmacol. 228, 95-102.
46. Wrighton, S.A., Campanile, C., Thomas, P.E., Paines, S.L., Watkins, P.B., Parker, G., Mendez-Picon, G., Haniu, M., Shively, J.E., Levin, W. and Guzelian, P.S. (1986) Identification of a human liver cytochrome P-450 homologous to the major isosafrole-inducible cytochrome P-450 in the rat. Mol. Pharmacol. 29, 405-410.